血管发育中的受体酪氨酸激酶信号传导 - Suppr

Suppr

超能文献

Receptor tyrosine kinase signaling in vascular development.

作者信息

Merenmies J, Parada L F, Henkemeyer M

机构信息

Center for Developmental Biology, University of Texas Southwestern Medical Center, Dallas 75235-9133, USA.

出版信息

Cell Growth Differ. 1997 Jan;8(1):3-10.

PMID:8993829

Abstract

摘要

相似文献

Receptor tyrosine kinase signaling in vascular development.血管发育中的受体酪氨酸激酶信号传导

Cell Growth Differ. 1997 Jan;8(1):3-10.

Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.血管内皮生长因子-弗林蛋白酶酪氨酸激酶受体系统在正常及肿瘤血管生成中的可能作用。

Princess Takamatsu Symp. 1994;24:162-70.

Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.肿瘤血管生成所必需的两种独立机制：通过干扰血管内皮生长因子受体途径或Tie-2途径抑制人黑色素瘤异种移植瘤的生长。

Cancer Res. 1999 Jul 1;59(13):3185-91.

A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.由orf病毒编码的一种新型血管内皮生长因子VEGF-E，通过VEGFR-2（KDR）而非VEGFR-1（Flt-1）受体酪氨酸激酶发出的信号介导血管生成。

EMBO J. 1999 Jan 15;18(2):363-74. doi: 10.1093/emboj/18.2.363.

[Role of the ETS transcription factors in the control of endothelial-specific gene expression and in angiogenesis].[ETS转录因子在调控内皮细胞特异性基因表达及血管生成中的作用]

Bull Cancer. 2001 Feb;88(2):137-42.

Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.血管内皮生长因子诱导的血管平滑肌细胞体外迁移

Microvasc Res. 1999 Sep;58(2):128-36. doi: 10.1006/mvre.1999.2171.

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.Flt-1受体酪氨酸激酶在调节血管内皮组装中的作用。

Nature. 1995 Jul 6;376(6535):66-70. doi: 10.1038/376066a0.

Regulation of angiogenesis via vascular endothelial growth factor receptors.通过血管内皮生长因子受体对血管生成的调节。

Cancer Res. 2000 Jan 15;60(2):203-12.

Angiogenesis in embryos and ischemic diseases.胚胎及缺血性疾病中的血管生成

Thromb Haemost. 1997 Jul;78(1):678-83.

Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex.血管内皮生长因子调节Tie-2:Tie-1受体复合物。

Microvasc Res. 2002 Mar;63(2):149-58. doi: 10.1006/mvre.2001.2377.

引用本文的文献

Evaluation of Osteogenesis and Angiogenesis of Icariin in Local Controlled Release and Systemic Delivery for Calvarial Defect in Ovariectomized Rats.淫羊藿苷局部控释和全身给药对去卵巢大鼠颅骨缺损成骨和血管生成的评价。

Sci Rep. 2017 Jul 11;7(1):5077. doi: 10.1038/s41598-017-05392-z.

Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion.血管生成抑制剂以维持光动力血管闭塞。

J Cell Mol Med. 2012 Jul;16(7):1553-62. doi: 10.1111/j.1582-4934.2011.01440.x.

The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.EphB4的可溶性细胞外结构域（sEphB4）可拮抗EphB4-EphrinB2相互作用，调节血管生成，并抑制肿瘤生长。

Blood. 2006 Mar 15;107(6):2330-8. doi: 10.1182/blood-2005-04-1655. Epub 2005 Dec 1.

Coordinated functions of Akt/PKB and ETS1 in tubule formation.Akt/PKB与ETS1在肾小管形成中的协同作用。

FASEB J. 2003 Dec;17(15):2278-80. doi: 10.1096/fj.03-0040fje. Epub 2003 Oct 2.

Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor.通过使用血管内皮生长因子受体拮抗剂靶向肿瘤相关血管生成来抑制肿瘤生长和转移。

Invest New Drugs. 1999;17(3):195-212. doi: 10.1023/a:1006314501634.

Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy.选定的受体酪氨酸激酶抑制剂PD166285和PD173074的抗血管生成活性：对与光动力疗法联合治疗的意义。

Invest New Drugs. 1999;17(2):121-35. doi: 10.1023/a:1006367032156.

Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice.胎盘血管生成缺陷导致VHL基因缺陷小鼠胚胎致死。

Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9102-7. doi: 10.1073/pnas.94.17.9102.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验